The cost-effectiveness of therapies currently used in routine practice

Recent advancements in the routine collection of data on treatment pathways of patients diagnosed with all forms of cancer has facilitated the cost-effectiveness analysis of therapies used in routine practice. This project aims to evaluate the cost-effectiveness of cancer therapies currently used in routine practice.

Project team

Sebastian Hinde, Claire McKenna, Mark Sculpher.


Claire McKenna. Click here to email Claire.